SEC Form 4 · accession 0001209191-18-057306
Tvardi Therapeutics, Inc. · TVRD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Frederique Menzaghi Ph.D.
Officer — Sr VP-Research & Development
Period of report
Aug 6, 2018
Accepted (ET)
Nov 5, 2018 · 8:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001346830
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 6, 2018 | M | 10,000 | $2.25 | A | 114,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $2.25 | Aug 6, 2018 | M | 10,000 | D | — | Aug 14, 2018 | Common Stock | 10,000 | 0 | D |
Explanation of responses
- F1Immediately exercisable.
Remarks
The Reporting Person filed three Forms 4 following the transaction reported hereby, which filings underreported the number of shares of common stock beneficially owned following the reported transactions by 10,000 shares. Those reports are deemed amended hereby.